BioMarin to Attend Upcoming Investor Conferences
04 May 2016 - 10:30PM
- Bank of America Merrill Lynch 2016 Health
Care Conference on May 11 in Las Vegas - Goldman Sachs
37th Annual Global Healthcare Conference on June 9 in Ranchos Palos
Verdes, California
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will
participate in the Bank of America Merrill Lynch 2016 Health Care
Conference on May 11, 2016 at 10:00am PT/1:00pm ET, in Las Vegas
and the Goldman Sachs 37th Annual Global Healthcare Conference on
June 9, 2016 at 10:00am PT/1:00pm ET, in Ranchos Palos Verdes,
California. To access the live webcasts, please visit the
investor section of the BioMarin website, www.BMRN.com. A replay
will also be archived on the site for at least one week following
the event.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for people with
serious and life-threatening rare disorders. The company's
portfolio consists of five commercialized products and multiple
clinical and pre-clinical product candidates.
For additional information, please visit
www.BMRN.com. Information on BioMarin's website is not incorporated
by reference into this press release.
Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2024 to May 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From May 2023 to May 2024